MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 56 filers reported holding MEDIVATION INC in Q3 2016. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $11,432,000 | +28.0% | 189,584 | -2.4% | 0.10% | +14.1% |
| Q1 2016 | $8,930,000 | -4.6% | 194,220 | +0.3% | 0.08% | -5.6% |
| Q4 2015 | $9,365,000 | +18.3% | 193,727 | +4.0% | 0.09% | +8.4% |
| Q3 2015 | $7,919,000 | -24.1% | 186,330 | +103.9% | 0.08% | -35.7% |
| Q2 2015 | $10,434,000 | -13.1% | 91,368 | -1.8% | 0.13% | -5.1% |
| Q1 2015 | $12,012,000 | +28.5% | 93,050 | -0.9% | 0.14% | +25.9% |
| Q4 2014 | $9,349,000 | +2776.6% | 93,850 | +1740.2% | 0.11% | +800.0% |
| Q4 2013 | $325,000 | – | 5,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,244,519 | $221,916,000 | 86.32% |
| BB BIOTECH AG | 1,429,706 | $141,355,000 | 5.75% |
| Selkirk Management LLC | 64,300 | $6,357,000 | 4.00% |
| Eventide Asset Management | 275,300 | $27,219,000 | 3.80% |
| HealthCor Management, L.P. | 525,000 | $51,907,000 | 2.67% |
| Quotient Investors, LLC | 110,856 | $10,960,000 | 2.39% |
| Orbimed Advisors | 2,273,000 | $224,732,000 | 2.35% |
| BENDER ROBERT & ASSOCIATES | 26,478 | $2,618,000 | 1.82% |
| Bain Capital Public Equity Management, LLC | 623,990 | $61,694,000 | 1.58% |
| Gerry Farber, LLC | 12,200 | $1,206,000 | 1.57% |